The merger combines the two companies’ data sets in order to expedite clinical trials and has the potential to send “shockwaves” through the industry, says ISR president.
AMRI has acquired the Italy-based chemical company, Euticals, in a move that expands its API development and manufacturing business.
Mass Innovation Labs is working to change the way biopharmaceutical companies conduct research by providing a “crossroads” for CRO service providers, vendors, and investors.
Germany's Merck has upped bioreactor capacity at its facility in Martillac, France in an investment it says broadens its biologics manufacturing offering.
Parexel has announced its financial results for the third quarter of FY16, which remained strong in spite of the complexities associated with smaller clinical trials.
Content Provided by Catalent
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier era, depriving sponsors of clinical supply models with the flexibility, speed and efficiency their programs demand. Now, that may be about to change with the advent of demand led supply (DLS), a clinical supply model tailored to today’s trials.